SCARDA to Invite Funding Applications for New Modality Research without Requiring PI Plans

SCARDA Director General Michinari Hamaguchi In the hunt for novel vaccine modalities from researchers outside the infectious disease arena, Japan’s Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) will partially ease its requirements for...read more